Study ID | Number | Study Title | Institute | Species | Analysis |
---|---|---|---|---|---|
ST000046 | 1 metabolites | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (plasma) | Mayo Clinic | Homo sapiens | MS |
ST000047 | 1 metabolites | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) | Mayo Clinic | Homo sapiens | MS |
ST000142 | 2 metabolites | H1299 13C-labeled Cell Study | University of Kentucky | Homo sapiens | MS |
ST000291 | 1 metabolites | LC-MS Based Approaches to Investigate Metabolomic Differences in the Urine of Young Women after Drinking Cranberry Juice or Apple Juice | University of Florida | Homo sapiens | MS |
ST000292 | 1 metabolites | LC-MS Based Approaches to Investigate Metabolomic Differences in the Plasma of Young Women after Drinking Cranberry Juice or Apple Juice | University of Florida | Homo sapiens | MS |
ST000310 | 1 metabolites | TC and B6 untreated plasma in lupus-prone mice lipidomics (part-II) | University of Florida | Mus musculus | MS |
ST000335 | 1 metabolites | Metabolomics of bovine uterine fluid at the onset of conceptus elongation | University of Florida | Bos taurus | MS |
ST000403 | 1 metabolites | Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes | Monash University | Homo sapiens | MS |
ST000421 | 1 metabolites | Type 1 Diabetes poor glycemic control versus control samples | Mayo Clinic | Homo sapiens | MS |
ST000422 | 1 metabolites | Type 1 Diabetes good glycemic control and controls samples | Mayo Clinic | Homo sapiens | MS |
ST000539 | 1 metabolites | Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes (part II) | Monash University | Homo sapiens | MS |
ST001192 | 1 metabolites | A library of human gut bacterial isolates paired with longitudinal multiomics data enables mechanistic microbiome research | The Broad Institute | Homo sapiens | MS |
ST001201 | 1 metabolites | Peroxide antimalarial treatment timecourse on trophozoite-stage P. falciparum parasites | Monash University | Plasmodium falciparum;Homo sapiens | MS |
ST001202 | 1 metabolites | Peroxide antimalarial treatment timecourse on ring-stage P. falciparum parasites | Monash University | Plasmodium falciparum;Homo sapiens | MS |
ST001204 | 1 metabolites | Peroxide antimalarial extended treatment timecourse on trophozoite-stage P. falciparum parasites | Monash University | Plasmodium falciparum;Homo sapiens | MS |
ST001205 | 1 metabolites | Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites | Monash University | Plasmodium falciparum;Homo sapiens | MS |
ST001549 | 1 metabolites | β-Adrenergic regulation of metabolism in macrophages (part-III) | Monash University | Homo sapiens | MS |
ST001788 | 1 metabolites | β-Adrenergic regulation of metabolism in macrophages (part-IV) | Monash University | Homo sapiens | MS |
ST002016 | 1 metabolites | Metabolomics of COVID patients | University of Virginia | Homo sapiens | MS |
ST002471 | 1 metabolites | Linking bacterial metabolites to disease-associated microbes to uncover mechanisms of host-microbial interactions in intestinal inflammation. Human stool profiling | Broad Institute of MIT and Harvard | Homo sapiens | MS |
ST002792 | 1 metabolites | Chemoproteomics validates selective targeting of Plasmodium M1 alanyl aminopeptidase as a cross-species strategy to treat malaria | Monash University | Plasmodium falciparum | MS |
ST003036 | 1 metabolites | Identifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa - Part 2 | Monash Institute of Pharmaceutical Sciences | Pseudomonas aeruginosa | MS |